FDA officials appeared before a congressional panel to answer questions about the crisis after Abbott Laboratories (NYSE:ABT) recalled some baby formula products and closed its manufacturing plant in Sturgis, Michigan.
"There are also questions surrounding the FDA's investigation and response timeline," said Representative Diana DeGette, chairwoman of the U.S. House of Representatives Commerce and Energy Subcommittee on Oversight and Investigations.
